Hyaluronic acid-coated chitosan nanoparticles as targeted-carrier of tamoxifen against MCF7 and TMX-resistant MCF7 cells

Tamoxifen (TMX) is used to treat hormone-receptor-positive breast cancers at early stages. This research aimed to assess the potential of NPs in targeted delivery of TMX against MCF7 and TMX-resistant MCF7 breast cancer cell lines. For this purpose, a targeted delivery system including chitosan NPs...

Descripción completa

Detalles Bibliográficos
Autores principales: Nokhodi, Fariba, Nekoei, Mehdi, Goodarzi, Mohammad Taghi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Delivery Systems
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843906/
https://www.ncbi.nlm.nih.gov/pubmed/35157166
http://dx.doi.org/10.1007/s10856-022-06647-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843906/
https://www.ncbi.nlm.nih.gov/pubmed/35157166
http://dx.doi.org/10.1007/s10856-022-06647-6

Ejemplares similares